The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: Protective effect of dipyridamole by Lana, Daniele et al.
ORIGINAL RESEARCH ARTICLE
published: 27 November 2014
doi: 10.3389/fnagi.2014.00322
The neuron-astrocyte-microglia triad in a rat model of
chronic cerebral hypoperfusion: protective effect of
dipyridamole
Daniele Lana1, Alessia Melani2, Anna Maria Pugliese2, Sara Cipriani3†, Daniele Nosi4, Felicita Pedata2
and Maria Grazia Giovannini1*
1 Section of Pharmacology and Clinical Oncology, Department of Health Sciences, University of Florence, Florence, Italy
2 Section of Pharmacology and Toxicology, Department of NEUROFARBA, University of Florence, Florence, Italy
3 Inserm U1141, Paris, France
4 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Edited by:
George E. Barreto, Pontificia
Universidad Javeriana, Colombia
Reviewed by:
Eric Blalock, University of Kentucky,
USA
Eszter Farkas, University of Szeged,
Hungary
*Correspondence:
Maria Grazia Giovannini, Section of
Clinical Pharmacology and
Oncology, Department of Health
Sciences, University of Florence,





Sara Cipriani, Inserm U1141, Paris,
France
Chronic cerebral hypoperfusion during aging may cause progressive neurodegeneration
as ischemic conditions persist. Proper functioning of the interplay between neurons and
glia is fundamental for the functional organization of the brain. The aim of our research
was to study the pathophysiological mechanisms, and particularly the derangement of the
interplay between neurons and astrocytes-microglia with the formation of “triads,” in a
model of chronic cerebral hypoperfusion induced by the two-vessel occlusion (2VO) in
adult Wistar rats (n = 15). The protective effect of dipyridamole given during the early
phases after 2VO (4mg/kg/day i.v., the first 7 days after 2VO) was verified (n = 15).
Sham-operated rats (n = 15) were used as controls. Immunofluorescent triple staining of
neurons (NeuN), astrocytes (GFAP), and microglia (IBA1) was performed 90 days after 2VO.
We found significantly higher amount of “ectopic” neurons, neuronal debris and apoptotic
neurons in CA1 Str. Radiatum and Str. Pyramidale of 2VO rats. In CA1 Str. Radiatum
of 2VO rats the amount of astrocytes (cells/mm2) did not increase. In some instances
several astrocytes surrounded ectopic neurons and formed a “micro scar” around them.
Astrocyte branches could infiltrate the cell body of ectopic neurons, and, together with
activated microglia cells formed the “triads.” In the triad, significantly more numerous
in CA1 Str. Radiatum of 2VO than in sham rats, astrocytes and microglia cooperated
in the phagocytosis of ectopic neurons. These events might be common mechanisms
underlying many neurodegenerative processes. The frequency to which they appear might
depend upon, or might be the cause of, the burden and severity of neurodegeneration.
Dypiridamole significantly reverted all the above described events. The protective effect
of chronic administration of dipyridamole might be a consequence of its vasodilatory,
antioxidant and anti-inflammatory role during the early phases after 2VO.
Keywords: apoptosis, phagocytosis, CA1, confocal microscopy, neuron-astrocyte-microglia triad
INTRODUCTION
Chronic ischemia is a progressive neurodegenerative process
caused by cerebral hypoperfusion that may manifest with cog-
nitive dysfunction as ischemic conditions persist (Sarti et al.,
2002b; Schmidt-Kastner et al., 2005; Melani et al., 2010). Chronic
hypoperfusion of the brain, secondary to vascular pathology, is a
prominent risk factor for neurodegenerative diseases (Naritomi,
1991) such as vascular dementia (Chmayssani et al., 2007). Age-
related cerebrovascular stenosis caused by arteriosclerosis induces
failure of brain circulation, and resolution of cerebral hypoper-
fusion has been reported to improve mental decline in humans
(Hirono et al., 1993; Nencini et al., 1993; Tsuda et al., 1994;
Tatemichi et al., 1995).
The reconstruction of a pathological condition in ani-
mal models is a suitable approach to the unraveling of the
pathophysiological mechanisms underlying neuronal damage.
For the reproduction of chronic cerebral hypoperfusion as it
occurs in human aging, the permanent, bilateral occlusion of
the common carotid arteries in rats (two-vessel occlusion, 2VO)
is a widely recognized procedure that allows to investigate the
mechanisms that link chronic cerebral hypoperfusion to neurode-
generative processes (Sarti et al., 2002a,b; Farkas et al., 2007).
Over the years, the 2VO model has generated a large amount
of data, revealing that hippocampal neurons have higher sen-
sitivity to ischemic insults compared to other cell populations.
Specifically, the CA1 region of the hippocampus is particularly
vulnerable to ischemia and to the 2VO-related pattern of hypop-
erfusion and metabolic changes, leading to failure of neuronal
signaling, and to learning and memory disturbances (Schmidt-
Kastner et al., 2001; Shibata et al., 2004; Farkas et al., 2006;
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Ohtaki et al., 2006; Melani et al., 2010). Since few pharmacolog-
ical therapies able to ameliorate neurodegeneration in patients
with chronic vascular pathologies are available, a major goal is
to elucidate the pathophysiological mechanisms that link chronic
hypoperfusion with alterations of brain functions to find targets
for new therapeutic strategies.
Although brain disease is generally attributed to malfunc-
tion or loss of neurons, it is becoming more and more evi-
dent that proper interplay between neurons-astrocytes-microglia,
the so called “triad,” is fundamental for the functional orga-
nization of the brain (Barres, 2008; Allen and Barres, 2009).
Impaired interplay among neurons and glia may be responsible
for derangements from normal brain physiology to neurode-
generative processes (De Keyser et al., 2008; Sofroniew, 2009).
Nevertheless, the precise role of microglia-astrocytes in neu-
rodegenerative diseases is not clearly defined and different, even
contrasting, aspects have to be considered. Signals produced by
neurons undergoing physiological apoptosis during normal brain
aging are different from signals induced during neurodegenera-
tive diseases (Lauber et al., 2004; Takahashi et al., 2005). How
apoptosis causes neurons to die is still a matter of debate, but it
is believed that the main means is by triggering production of
signals which induce phagocytic cells to eat the neuron (Noda
et al., 2011). Therefore, if on one side microglia and astrocytes
can be neuroprotective (Faulkner et al., 2004; Myer et al., 2006;
Hanisch and Kettenmann, 2007; Li et al., 2008), on the other
one they can be dangerous for neuronal health (Block et al.,
2007).
This work was aimed at understanding the pathophysi-
ological mechanisms underlying chronic brain ischemia. We
have demonstrated, in normal brain aging and in a model of
brain inflammation, that astrocytes and microglia actively col-
laborate in the clearance of apoptotic neurons and neuronal
debris associated with apoptosis (Cerbai et al., 2012). We used
the 2VO model of cerebral hypoperfusion in the rat to ver-
ify whether this phenomenon may be a common mechanism
underlying different neurodegenerative processes. Astrocytes and
microglia may exert either protective mechanisms to control
inflammatory processes and the spread of further cellular dam-
age to neighboring tissue or may contribute to neuronal dam-
age along the progression of the pathological conditions. A
better understanding of risks and benefits of astrocyte and
microglia activation is critical to determine whether future ther-




Male adult Wistar rats (3 months old, Harlan, Milano, Italy)
were used. The animals were housed in cages with ad libitum
food and water and were maintained on a 12 h light–12 h dark
cycle in a temperature-controlled room (23 ± 1◦C). Experiments
were approved by the IACUC of the University of Florence
and performed according to the Italian Law on Animal Welfare
(DL 116/92, Italian Directive on the protection of animals used
for scientific purposes, application of the EU 609/86 directive).
All efforts were made to minimize animal sufferings and to
use only the number of animals necessary to produce reliable
scientific data.
SURGERY
Bilateral common carotid artery occlusion (2VO) was carried
out in rats (Sarti et al., 2002a,b; Farkas et al., 2007) as follows,
according to the scheme represented in Figure 1A. Anesthesia
was induced with 5% halothane and maintained with sponta-
neous respiration of 1/2% halothane in air by use of a face mask.
Body temperature was maintained at 37◦C with a recirculating
pad and K module and was monitored via an intrarectal type T
thermocouple (Harvard, Kent, UK). The right common carotid
artery was occluded, (day-7, Figure 1A), as follows. The skin
of the ventral part of the neck was incised and the omohyoid
muscle was cut through a median incision. Using a microscope,
the common carotid artery was exposed and firmly ligated with
a silk suture. In sham-operated rats the same procedure was
applied without the ligature. After 1 week (day 0, Figure 1A), the
same procedure was repeated to occlude the left common carotid
artery. After each surgical procedure, rats were treated daily with
diaminocillin (1,200,00 U in 8ml saline, 1ml/day i.m.). Animals
were randomly subdivided in three experimental groups: sham-
operated rats (sham, n = 15), 2VO-operated rats treated with
vehicle (2VO-vehicle, n = 15), and 2VO-operated rats treated
with dipyridamole (2VO-dipyridamole, n = 15) from day 0 to
day 7.We did not include the sham-dipyridamole-treated animals
group in the project because we wanted to verify the effect of the
drug in 2VO treated rats.
DRUG ADMINISTRATION
Dipyridamole (Persantin, Boehringer Ingelheim, 5mg/mL) was
administered by intravenous perfusion to obtain stable con-
centrations of the drug in the blood. Dipyridamole or vehi-
cle were injected (10µL/h per 7 days) into the jugular vein
by a miniosmotic pump (Model 2001, Alzet, Cupertino, CA,
USA) attached to a silicone catheter (0.51mm ID × 0.07 wall;
Alzet) and prefilled with drug or vehicle in sterile conditions,
followed by a 12-h preimplantation incubation at 37◦C. The
pumps were implanted subcutaneously in the thoraco-lumbar
region immediately after the left common carotid artery occlu-
sion and removed after 7 days (Figure 1A). Considering the
body weight of rats (about 300 g), each animal received about
4mg/kg/day of dipyridamole. On the basis of a previous estima-
tion of dipyridamole plasma concentration in the rat, we esti-
mated that administration of 4mg/kg dipyridamole i.v. provides
a 2–2.5µM plasma concentration over the entire week (Newell
et al., 1986). The dose of dipyridamole administered in this study
is similar to that (0.5–3mg/kg i.v.) used by Jones (Jones et al.,
1994). This concentration (equivalent to 1µg/mL) is close to the
therapeutic concentration (1.6µg/mL) reached after extended-
release dipyridamole administered to ischemic stroke patients
(Serebruany et al., 2009).
IMMUNOHISTOCHEMISTRY
Ninety days after surgery, rats were anesthetized (chloral hydrate,
400mg/kg) and perfused transcardially with 500ml of ice-cold
paraformaldehyde (4% in phosphate-buffered saline, PBS, pH
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FIGURE 1 | (A) Experimental scheme. Chronic hypoperfusion in the rat was
obtained by occlusion of the Right and Left common carotid arteries
separately, 7 days apart. Dipyridamole was administered i.v. for 7 days. (B)
Representation of the regions of Interest (ROI) in CA1 hippocampus Str.
Pyramidale and Str. Radiatum where all imunohistochemical analyses were
performed. (C) Representation of a triple immunostaining of a
neuron-astrocyte-microglia triad. Neuron (NeuN positive, red), astrocyte
(GFAP positive, green), microglia (IBA1 positive, blue). Scale bar: 5µm.
7.4). Brains were postfixed for 4 h and cryoprotected in 18%
sucrose/PBS for at least 48 h. Coronal sections (thickness 40µm)
were cut with a cryostat, placed in 1ml of anti-freeze solution
(40% PBS, 30% Ethylene-Glycol, 30%, Glycerol, v/v) and stored
at −20◦C until immunohistochemistry.
Antibodies
The following primary antibodies were used: a mouse mono-
clonal anti-neuronal nuclei (NeuN, 1:200; Millipore, Billerica,
MA) for neurons; a rabbit polyclonal anti-glial fibrillary acidic
protein (GFAP, 1:1000; DakoCytomation, Glostrup, Denmark)
for astrocytes; a rabbit polyclonal anti-IBA1 (1:300, WAKO
Pure Chem. Ind., Osaka, Japan) for microglia; a mouse mono-
clonal anti-Cytochrome C (Cyt C, 1:200, Becton and Dickinson,
Franklin Lakes, NJ, USA) as an apoptotic marker. In triple stain-
ing for astrocytes, microglia and neurons, astrocytes were labeled
with a mouse monoclonal anti-GFAP antibody conjugated with
the fluorochrome AlexaFluor 488 (1:500), in triple staining for
neurons, microglia and cytochrome C, neurons were labeled
with a mouse monoclonal anti-NeuN antibody conjugated with
the fluorochrome AlexaFluor 488 (1:500), both from Millipore,
Billerica, MA.
The following fluorescent secondary antibodies were used:
AlexaFluor 488 donkey anti-rabbit (1:400), AlexaFluor 594
goat anti-mouse (1:400), AlexaFluor 555 donkey anti-mouse
(1:400), Alexa Fluor 635 goat anti-rabbit (1:400) (all from Life
Technologies, Carlsbad, CA, USA). Colocalization of different
antigens was performed using combinations of different primary
and secondary antibodies, using double or triple labeling confo-
cal microscopy. Nuclei were stained using DAPI (Vectashield hard
set mounting medium containing DAPI, Vector Laboratories).
Fluorescent immunohistochemistry
Immunostaining was performed on coronal slices with the free-
floating method (Giovannini, 2002). Day 1. Free-floating slices
(40µm thick) were placed in wells, were rinsed three times for
5min in PBS-TX and then were blocked for 60min with BB con-
taining 10% Normal Goat Serum–10% Normal Horse Serum in
PBS-TX and 0.05% NaN3. Slices were incubated overnight at 4◦C
under slight agitation with a combination of two different pri-
mary antibodies dissolved in BB (depending on the antigens we
wanted to visualize).
Day 2. For double immunostaining, slices were incubated
for 2 h at room temperature in the dark with the appropriate
secondary antibody (see above).
For triple immunostaining, slices were incubated for 2 h at
room temperature in the dark with AlexaFluor 555 donkey
anti mouse IgG (1:400) secondary antibody and then for 2 h
at room temperature in the dark with AlexaFluor 555 don-
key anti mouse IgG (1:400) plus Alexa Fluor 635 goat anti-
rabbit (1:400). Depending on the antigens to be visualized,
after 3 washings, astrocytes were immunostained using the
primary antibody anti-GFAP AlexaFluor 488-conjugated and
neurons were immunostained using the primary antibody anti-
NeuN AlexaFluor 488-conjugated. For both double and triple
immunostaining procedures, slices were mounted onto gelatin-
coated slides using Vectashield hard set mounting medium with
DAPI (Vector Laboratories).
Widefield and confocal fluorescence microscopy
Slices were observed under an epifluorescent microscope
Olympus BX40 equipped with an Olympus DP 50 digital camera
(Olympus, Milan, Italy) or under a LEICA TCS SP5 confocal
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laser scanning microscope (Leica Microsystems CMS GmbH,
Mannheim, Germany). Confocal scans were taken at 0.3µm z-
steps keeping pinhole, contrast and brightness constant. Voxel size
was 6.75 × 10−3 µm3. Images were digitally converted to green,
red or blue using Image J (National Institute of Health, http://
rsb.info.nih.gov/ij), digitally combined to obtain single, double
or triple labeled images and then assembled into montages. High
power 3D renderings of the images were obtained using Image J
3D viewer.
METHODOLOGICAL CONSIDERATIONS
All quantification analyses were performed by two researchers
blind to the experimental conditions and results were aver-
aged. Three coronal slices (spaced by 150µm, starting at
about −2.8mm from bregma) containing the dorsal hippocampi
were immunostained. Since no differences was ever found
between the two hippocampi (Sarti et al., 2002b and unpub-
lished results) the regions of interest (ROI) of both CA1 areas,
containing Str. Pyramidale or Str. Radiatum were consistently
captured at 20× magnification using an Olympus digital camera
(framed area in Figure 1B). Areas of ROI in CA1 were calcu-
lated in mm2. Astrocytes, microglia, ectopic neurons, neuronal
debris, and the triads (neurons-astrocytes-microglia) in CA1 Str.
Radiatum, and apoptotic neurons and DAPI positive cells in CA1
Str. Pyramidale were consistently counted in the same area in all
slices and were expressed as cells/mm2. DAPI stained cells con-
stitute the total cell population in CA1 Str. Pyramidale (neurons
plus astrocytes plus microglia). Subtracting the number of GFAP
positive astrocytes and IBA1 positive microglia in Str. Pyramidale
from total DAPI stained cells it is possible to obtain the num-
ber of neurons in CA1 Str. Pyramidale. Therefore, quantitation
of CA1 pyramidal neurons was obtained subtracting the number
of astrocytes and microglia cells (counted separately) from the
total of DAPI positive cells in CA1 Str. Pyramidale. We defined
“triad” a neuron that was in direct contact with a microglia
cell and astrocyte branches deriving from surrounding astro-
cyte(s), as exemplified by the confocal 3D rendering shown in
Figure 1C. Cell debris was defined as NeuN-positive fragments
with dimensions between 2.5 and 6.5µm. NeuN immunostan-
ing labels a protein that is located not only in the nuclei, but
also in the surrounding cytoplasm and in the proxymal parts
of dendrites, as visible from images present in our and others’
work (Cobos et al., 2005; Cerbai et al., 2012). Therefore, it is
plausible that debris are NeuN positive. The criteria to character-
ize a microglia cell as “resting” or “reactive” were defined before
evaluation as follows. In accordance to the literature (Stence
et al., 2001; Nelson et al., 2002; Rezaie et al., 2002; Herber et al.,
2006; Miller and Streit, 2007) resting microglia were defined as
cells with small, round cell bodies with thin and highly rami-
fied branches equally distributed around the cell body. Reactive
microglia were defined as cells with a large pleomorphic bi-or
tri-polar cell body, or as spindle or rod-shaped cells with mod-
ification in cellular structure that included de-ramification and
shortening and twisting of cellular processes (Cerbai et al., 2012).
In order to unambiguously define whether astrocyte branches
were infiltrating neurons we digitally cut the 3D rendering of
the cell along a vertical plane and rotated the image around
the cell vertical axis by 45 and 90◦. Confocal qualitative dou-
ble or triple immunostaining analyses were performed in 2VO-
vehicle (n = 6), 2VO-dipyridamole (n = 6), and sham rats (n =
6). To verify the specificity of the staining, control immunos-
taining was performed omitting the primary or secondary
antibodies.
STATISTICAL ANALYSIS
Statistical comparisons were performed using Graph Pad Prism
(Graph Pad Software Inc., La Jolla, CA, USA) by One-Way
ANOVA followed by Newman–Keuls Multiple Comparison
Test, or Two-Way ANOVA followed by Bonferroni multiple
comparison test, as appropriate. Significance was set at P < 0.05.
RESULTS
We previously demonstrated in two different animal models of
neurodegeneration that astrocytes andmicroglia appear to collab-
orate in the clearance of apoptotic neurons and neuronal debris
in the CA1 region of the hippocampus (Cerbai et al., 2012).
Using the novel method of simultaneous triple immunostaining
of neurons, astrocytes and microglia, we further characterized the
interplay among neurons and glia in this animal model of chronic
cerebral hypoperfusion and neurodegeneration.
“ECTOPIC” NEURONS AND NEURONAL DEBRIS IN THE CA1 Str.
RADIATUM
Immunostaining of neurons using the anti-NeuN antibody
revealed the presence of numerous neurons, that we defined
“ectopic,” scattered throughout the CA1 Str. Radiatum of
sham (Figures 2A,A1), 2VO-vehicle (Figures 2B,B1), and 2VO-
dipyridamole rats (Figures 2C,C1). Ectopic neurons were mostly
present in the Str. Radiatum within 100µm from the Str.
Pyramidale, (arrows in Figures 2A1–C1, magnifications of the
framed areas shown in Figures 2A–C). Quantitative analysis per-
formed in the Str. Radiatum showed that ectopic neurons were
significantlymore numerous (+49%) in the CA1 Str. Radiatum of
2VO-vehicle rats than in sham operated rats. Dipyridamole com-
pletely reverted this phenomenon [Figure 2D, One-Way ANOVA
F(2, 20) = 6.844; P = 0.0054; ∗at least P < 0.05 vs. both other
groups, Newman–Keuls Multiple Comparison Test].
We evaluated whether chronic hypoperfusion might cause loss
of CA1 pyramidal neurons. Cells were counted in the ROI of sham
(Figure 3A), 2VO-vehicle (Figure 3B), and 2VO-dipyridamole
rats (Figure 3C) (framed area in Figure 3A; for the procedure
see Methodological considerations). Results in Figure 3D show
that the amounts of CA1 pyramidal neurons (cells/mm2) were
not significantly different among the three experimental groups
[One-Way ANOVA F(2, 32) = 1.56; P = 0.226, n.s.].
QUANTIFICATION OF ASTROCYTES IN THE CA1 Str. PYRAMIDALE AND
IN CA1 Str. RADIATUM
In order to verify the hypothesis that astrocytes and microglia
might actively collaborate in the triad formation around apop-
totic neurons and neuronal debris in the CA1 region of the
hippocampus of 2VO rats (Cerbai et al., 2012), we studied
the interplay among neurons and microglia using the triple
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FIGURE 2 | Quantitative analysis of ectopic neurons in CA1 Str.
Radiatum. (A–C) Representative photomicrographs of immunostained
neurons (NeuN positive), taken at an epifluorescent microscope, in CA1 Str.
Pyramidale and CA1 Str. Radiatum of a sham (A), a 2VO-vehicle (B), and a
2VO-dipyridamole rat (C). Images show the presence of ectopic neurons in
the Str. Radiatum within 100µm from the Str. Pyramidale. Scale bar: 70µm.
(A1–C1) Higher magnification images of the framed areas shown in (A–C),
respectively. Arrows indicate ectopic neurons. Scale bar: 25µm. (D)
Quantitative analysis of ectopic neurons in CA1 Str. Radiatum of sham (white
column, n = 7), 2VO-vehicle (black column, n = 8), and 2VO-dipyridamole
(gray column, n = 8) rats (ectopic neurons/mm2; mean ± s.e.m.; ∗at least
P < 0.05 vs. sham and 2VO-dipyridamole rats, One-Way ANOVA followed by
Newman–Keuls Multiple Comparison Test). Quantification was performed
blind by two researchers in the region of interest (ROI) of CA1 Str. Radiatum
and results were averaged. ROIs were calculated in mm2 and the counts of
NeuN immunopositive cells were expressed as neurons/mm2.
immunostaining of neurons, astrocytes, and microglia in the CA1
Str. Pyramidale and CA1 Str. Radiatum of sham, 2VO-vehicle and
2VO-dipyridamole rats.
Confocal images in Figures 4A–D show the close interplay
between an ectopic neuron immunostained with anti-NeuN anti-
body (red) and an astrocyte with anti-GFAP antibody (green)
in the CA1 Str. Radiatum of a 2VO-vehicle rat. To better
visualize this phenomenon the cell confocal 3D rendering of
the neuron shown in Figure 4A was digitally rotated by 90◦
(Figure 4B), 180◦ (Figure 4C), and 270◦ (Figure 4D) around
its vertical axis. It is evident from the images that astrocyte
branches (arrows) are in intimate relationship with the neu-
ronal cell body (see also Supporting Information “Media File 1”).
Indeed, in the CA1 Str. Radiatum of 2VO-vehicle rats ectopic
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FIGURE 3 | Quantitative analysis of cells labeled with DAPI in CA1 Str.
Pyramidale. (A–C) Representative photomicrographs, taken at an
epifluorescent microscope, of DAPI staining in CA1 Str. Pyramidale of a
sham (A), a 2VO-vehicle (B), and a 2VO-dipyridamole rat (C). Scale bar:
50µm. (D) Quantitative analysis of DAPI positive pyramidal neurons in CA1
Str. Pyramidale of sham (white column, n = 12), 2VO-vehicle (black column,
n = 12), and 2VO-dipyridamole (gray column, n = 11) rats (DAPI positive
neurons/mm2; mean ± s.e.m.; not significant, One-Way ANOVA).
Quantification of CA1 pyramidal neurons was obtained subtracting the
quantity of GFAP positive astrocytes and IBA1 positive microglia from the
total of DAPI positive cells in CA1 ROI (area highlighted by the dashed
rectangle in A). Quantification was performed blind by two researchers in
the region of interest (ROI) of CA1 Str. Pyramidale (framed area in A) and
results were averaged. ROIs were calculated in mm2 and the counts of
DAPI positive neurons were expressed as cells/mm2.
neurons were often surrounded by astrocyte branches, which were
in close proximity to the cell body, embracing and apparently
wedging them.
Astrocytes were quantified in the ROI of Str. Radiatum, as
shown in the representative images of sham (Figure 4E), 2VO-
vehicle (Figure 4F), and 2VO-dipyridamole rats (Figure 4G).
Quantitative analysis (Figure 4H) showed that GFAP positive
cells did not change significantly in CA1 Str. Radiatum of 2VO-
vehicle rats in comparison to the other experimental groups
[One-Way ANOVA F(2, 26) = 2.135; P = 0.1385, n.s.].
Neurons, astrocytes, and microglia were triple immunostained
in the CA1 of sham (n = 6), 2VO-vehicle (n = 6), and 2VO-
dipyridamole (n = 6) rats. Triple immunostaining of astrocytes
with anti-GFAP antibody (green), neurons with anti-NeuN anti-
body (red), and microglia with anti-IBA1 antibody (blue) in the
CA1 Str. Radiatum of a 2VO-vehicle rat clearly show the presence
of a neuron-astrocytes- microglia triad (Figure 4I). It is clearly
visible from the image that an ectopic neuron is surrounded by
astrocyte branches deriving from at least 4 different astrocytes
(arrowheads) that form a scar around it. Although not more
numerous, astrocytes appeared to be more active in the CA1
Str. Radiatum of 2VO-vehicle rats in comparison to sham and
2VO-dipyridamole animals.
The confocal 3D rendering of the neuron shown in Figure 4I
was digitally cut along the dotted white line (Figure 4L1), and
the 3D rendering was digitally rotated by 45◦ (Figure 4L2) and
90◦ (Figure 4L3) around its vertical axis to visualize the inside of
the neuronal cell body. It is clearly visible from Figures 4L2,L3
(arrows) that an astrocyte branch infiltrates the neuronal cell
body. These morphological features are consistent with the
hypothesis that astrocytes are bisecting a ectopic neuron to form
neuronal debris (further proof is provided below in the next
paragraphs).
To complete the triad is the presence of a microglia cell
(IBA1 positive, blue) in close contact with the neuronal cell
body and possibly phagocytosing the neuron. Indeed, it is clearly
visible from the magnifications in Figures 4M1–M3 that a reac-
tive microglia cell, which has lost most of its branches and
has acquired an almost amoeboid shape typical of phagocytic
microglia (Beynon and Walker, 2012), wraps and phagocy-
toses the neuron (arrow in Figure 4M1). Portion of the neu-
ronal cytoplasm is clearly missing (open arrow in Figure 4M2).
Figure 4M2 also clearly shows the grooves formed by the
astrocyte branches infiltrating the neuronal cytoplasm (arrow-
head), which correspond to the astrocyte branches that pen-
etrate the neuronal cell body (pointed out by the arrows in
Figures 4L2,L3). Triple immunostaining confocal 3D renderings
were taken from shams (n = 4), 2VO-vehicle (n = 5), and 2VO-
dipyridamole rats (n = 4) and the neuron-astrocytes-microglia
triads which were often found in 2VO-vehicle rats, were more
rarely observed in sham and 2VO-dypiridamole rats (see also
Figure 8D).
QUANTIFICATION OF NEURONAL DEBRIS IN CA1 Str. RADIATUM
As already demonstrated in aged and LPS-treated rats (Cerbai
et al., 2012), astrocytes branches infiltrating the neuronal cell
body seem to be fragmenting ectopic neurons to form debris,
thus cooperating with the microglia in phagocytic events. NeuN
staining revealed the presence of neuronal debris (NeuN posi-
tive fragments 2.5–6.5µm in diameter) scattered throughout the
CA1 Str. Radiatum of sham, 2VO-vehicle and 2VO-dipyridamole
rats (arrowheads in Figures 5A1–C1). Quantitative analysis in the
ROI of Str. Radiatum (framed areas in Figures 5A–C) showed
that neuronal debris were significantly more numerous in the
CA1 Str. Radiatum of 2VO-vehicle rats (+37%) than in sham rats
(Figure 5D). Dypiridamole completely reverted this effect [One-
Way ANOVA F(2, 27) = 6.752; P = 0.0042; ∗at least P < 0.05 vs.
two other groups, Newman–Keuls Multiple Comparison Test].
QUANTIFICATION OF MICROGLIA IN CA1 Str. RADIATUM
We performed immunostaining of microglia (using the anti IBA1
antibody) in the CA1 Str. Radiatum of the three experimental
groups. IBA1 positive resting and reactive microglia cells, char-
acterized as described in the Materials and Methods Section,
were quantified in the ROI of Str. Radiatum (Figures 6A–C).
Each column in Figure 6D, subdivided into reactive microglia
(white) and resting microglia (black), represents total microglia
(cells/mm2) in the CA1 Str. Radiatum of the three experimental
groups. In 2VO-vehicle rats, both resting and reactive microglia
decreased slightly in comparison to shams (−9 and −14%,
respectively), but these differences were not statistically signifi-
cant (One-Way ANOVA, n.s.). Total microglia cells slightly but
significantly decreased in CA1 Str. Radiatum of 2VO-vehicle rats
[−18% vs. sham rats, One-Way ANOVA, F(2, 23) = 4.194; P =
0.028; ∗P < 0.05 vs. two other groups, Newman–Keuls Multiple
Comparison Test], and dipyridamole reverted this effect (−2% vs.
sham, n.s.).
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FIGURE 4 | Neuron-astrocyte-microglia interplay and quantification of
astrocytes. (A–D) Double immunostaining of neurons (red) and astrocytes
(green). The confocal images represent 3D renderings of 49 confocal scans
(total thickness 14.7µm) acquired starting at 0.3µm depth into the slice. The
confocal image shown in (A) was digitally rotated by 90◦ (B), 180◦ (C), and
270◦ (D) around its vertical axis. Scale bar: 7.5µm. (E–G) Representative
epifluorescent photomicrographs of GFAP immunostained astrocytes in CA1
Str. Radiatum of a sham (E), a 2VO-vehicle (F), and a 2VO-dipyridamole rat (G).
GFAP positive astrocytes were counted in Str. Radiatum (ROI as represented
in E–G). Scale bar: 50µm. (H) Quantitative analysis of GFAP positive
astrocytes in CA1 Str. Radiatum of sham (white column, n = 11), 2VO-vehicle
(black column, n = 8), and 2VO-dipyridamole rats (gray column, n = 10)
counted as described above (GFAP positive cells/mm2; mean ± s.e.m.; n.s.,
One-Way ANOVA). Quantification was performed blind by two researchers
and results were averaged. ROIs were calculated in mm2 and the counts of
astrocytes were expressed as neurons/mm2. (I–L3) Representative confocal
images of triple immunostaining of astrocytes (green), neurons (red, open
arrow), and microglia (blue) in the CA1 Str. Radiatum of a 2VO-vehicle rat. The
3D confocal rendering in (I) was obtained from 30 confocal scans (total
thickness 9.0µm) acquired starting at 3µm depth into the slice. Arrowheads
show the bodies of 4 astrocytes projecting their branches toward the neuron
and forming a glia “micro scar” around it. The 3D confocal rendering in (I) was
digitally cut along the white dotted line (L1) and rotated by 45◦ (L2) and 90◦
(L3) around the vertical axis. Arrows in (L2, L3) show that an astrocyte branch
infiltrates the neuronal cell body. Scale bar in I–L3: 10µm. (M1–M3) High
magnification confocal renderings of the neuron-astrocyte-microglia triad
shown in (I). Arrow in (M1) indicates an IBA1-positive microglia cell
phagocytosing the neuron. Panel (M2) shows a neuron immunostained for
NeuN. The open arrow indicates that neuronal cytoplasm is missing
underneath the phagocitosing microglia cell. Arrowhead shows the grooves
formed by astrocyte branches infiltrating the neuron cell body. Panel (M3)
shows the IBA1 positive amoeboid microglia cell. Scale bar: 5µm.
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FIGURE 5 | Quantitative analysis of neuronal debris in CA1 Str.
Radiatum. (A–C) Representative photomicrographs, taken at an
epifluorescent microscope, of NeuN immunostaining in CA1 Str.
Pyramidale and CA1 Str. Radiatum of a sham (A), a 2VO-vehicle (B), and a
2VO-dipyridamole rat (C) showing the presence of NeuN positive debris in
the Str. Radiatum (arrowheads in the magnifications A1–C1). Neuronal
debris were defined as NeuN-positive fragments with dimensions ranging
between 2.5 and 6.5µm. Scale bar: 75µm. (A1–C1) High magnification
images of the framed areas shown in (A–C). Scale bar: 10µm. (D)
Quantitative analysis of neuronal debris in CA1 Str. Radiatum of sham
(white column, n = 9), 2VO-vehicle (black column, n = 10), and
2VO-dipyridamole rats (gray column, n = 11) counted in CA1 Str. Radiatum
(debris/mm2; mean ± s.e.m.; ∗at least P < 0.05 vs. sham and vs.
2VO-dipyridamole rats; One-Way ANOVA and Newman–Keuls Multiple
Comparison Test). Quantification was performed blind by two researchers
in the region of interest (ROI) of CA1 Str. Radiatum and results were
averaged. ROIs were calculated in mm2 and the counts of NeuN positive
debris were expressed as neurons/mm2.
CHARACTERIZATION AND QUANTIFICATION OF
NEURON-ASTROCYTES-MICROGLIA TRIADS IN CA1 Str. RADIATUM
Although microglia cells in the CA1 Str. Radiatum of 2VO-
vehicle rats were less numerous than in sham rats, microglia was
still actively involved in phagocytosis of neurons, as shown in
the representative confocal images presented in Figure 7, taken
from three independent 2VO-vehicle rats. Indeed, the confocal
3D renderings (Figures 7A–C), show that astrocytes (green) and
microglia (blue) are in close interactions with neurons (red),
forming triads. Figure 7A, taken from a 2VO-vehicle rat shows
that a microglia cell (blue), which has an almost amoeboid shape,
is in close contact with a neuronal cell body in the CA1 pyrami-
dal cell layer. Figure 7A1 represents a magnification of the framed
area in Figure 7A. It is clearly visible that part of the neuronal cell
body is internalized within the microglia cytoplasm (Figure 7A1,
arrowhead). It is also apparent from Figure 7A that this pyra-
midal neuron seems to be in the process of detaching from the
pyramidal cell layer. Indeed, an empty space, evidenced by the
two arrows, is forming around the neuron in the pyramidal cell
layer.
Figure 7B shows a confocal 3D rendering of an immunos-
tained hippocampal slice taken from a different 2VO-vehicle rat.
The image shows that a neuron (open arrow), located within
20µm from the CA1 Str. Pyramidale, is in close contact with
both astrocyte branches and a microglia cell. Panels 7B1–B3 rep-
resent magnifications of the framed area of Figure 7B and clearly
show that a reactive microglia cell, with an enlarged cell body and
thick and short branches, is in close contact with the neuronal
cell body and is starting to phagocytose it (see the open arrow in
Figure 7B2, indicating themissing cytoplasm under themicroglia
cell).
Figure 7C, taken in the Str. Radiatum of a third 2VO-vehicle
rat, shows that two ectopic neurons are embraced by astro-
cyte branches deriving from different astrocytes and forming a
“micro scar” around them, as also demonstrated in Figure 4I. The
two ectopic neurons are in close contact with reactive microglia
cells that are phagocytosing them (see below). The microglia
cell pointed out by the open arrow has a fusiform shape, while
the other one has an almost amoeboid shape, both typical of
reactive microglia (Beynon and Walker, 2012). Magnifications
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FIGURE 6 | Quantitative analysis of resting and reactive microglia
cells. (A–C) Representative photomicrographs, taken at an epifluorescent
microscope, of IBA1 positive cells in CA1 Str. Radiatum of a sham (A), a
2VO-vehicle (B), and a 2VO-dipyridamole rat (C). Scale bar: 50µm. (D)
Quantitative analysis of microglia cells in CA1 Str. Radiatum of sham
(n = 8), 2VO-vehicle (n = 8), and 2VO-dipyridamole rats (n = 11). Black
portion of columns represent resting microglia cells, white portion of
columns represent reactive microglia cells, the entire columns represent
total microglia cells. Total microglia in 2VO-vehicle rats was significantly
different from sham and 2VO-dipyridamole rats (IBA1 positive cells/mm2;
mean ± s.e.m.; ∗P < 0.05 vs. the two other groups, One-Way ANOVA and
Newman–Keuls Multiple Comparison Test). Resting and reactive microglia
did not differ among the three experimental groups. Quantification was
performed blind by two researchers in the region of interest (ROI) of CA1
Str. Radiatum (represented in A–C) and results were averaged. ROIs were
calculated in mm2 and the counts of resting and reactive microglia were
expressed as neurons/mm2.
of the framed area in Figure 7C are shown in panels 7C1–C3.
Astrocytes were omitted for clarity. Again, the images clearly show
that a reactive, almost amoeboid microglia cells is phagocytosing
the neuron, since part of the neuronal cytoplasm is internal-
ized within the microglia cell (Figure 7C1, arrowheads) and part
of the neuronal cytoplasm is clearly missing (open arrows in
Figure 7C2) beneath the microglia cell body.
Further representative images of neurons-astrocytes-microglia
triads from sham, 2VO-dipyridamole and 2VO-vehicle rats are
shown in Figures 8A–C. Quantitative analysis of the neuron-
astrocytes-microglia triads (as defined in Methodological con-
siderations) was performed in ROI of CA1 Str. Radiatum of
shams (n = 4), 2VO-vehicle (n = 5), and 2VO-dipyridamole rats
(n = 4). Results show that triads significantly increased in Str.
Radiatum of 2VO-vehicle rats [triad/mm2; +167% vs. sham rats;
One-Way ANOVA F(2, 10) = 23.01; P = 0.0003; ∗∗∗P < 0.001 vs.
two other groups, Newman–Keuls Multiple Comparison Test].
Dipyridamole significantly prevented this effect (+12% vs. sham
rats; n.s.).
QUANTIFICATION OF APOPTOTIC NEURONS IN CA1 Str. PYRAMIDALE
It was previously demonstrated, in a similar animal model of
chronic hypoperfusion, that CA1 pyramidal neurons undergo
apoptotic death between 2 and 25 weeks after the onset of
2VO (Bennett et al., 1998). Therefore, in order to verify in our
model whether neurons undergoing phagocytosis by microglia
were apoptotic, hippocampal slices from sham, 2VO-vehicle, and
2VO-dipyridamole rats were triple immunostained with anti-
NeuN for neurons (red), with anti-CytC, a marker for apoptosis
(green), and with anti-IBA1 for microglia (blue) (Figures 9A–D).
The presence of a diffuse CytC immunostaining in the cyto-
plasm is an indication that the cell is undergoing apoptosis (Suen
et al., 2008). Indeed, it has been demonstrated that at late stages
of apoptosis CytC, following complete release from the mito-
chondria, becomes visible in the cytoplasm (Suen et al., 2008).
Figure 9A shows immunostaining of neurons, Figure 9B of CytC,
and Figure 9C of microglia (IBA1 positive). The merge of the
three images is shown in Figure 9D. Colocalization of anti-CytC
with NeuN was present in the cytoplasm of some CA1 pyra-
midal neurons and in ectopic neurons (Figure 9D). Some of
these apoptotic CytC positive neurons were in close contact with
microglia cells possibly in the act of phagocitosing the dying neu-
ron (Figure 9D). From Figure 9D it is interesting to note that the
CytC immunopositive ectopic neuron is located within 20µm
from the pyramidal cell layer. An empty spot is clearly visible
in the pyramidal cell layer (asterisk), possibly in correspondence
to the place where the neuron was previously located. All CytC
positive pyramidal cells were neurons since they were also NeuN
positive. CytC positive neurons in Str. Pyramidalys, evidenced in
Figures 9E1–E3 by the arrows, were counted. Quantitative anal-
ysis shown in Figure 9F demonstrate that CytC positive cells
were significantly more numerous in 2VO-vehicle rats (+76%;
n = 10) than in sham rats (n = 12). Dypiridamole (n = 10)
significantly reverted this effect, although not completely [One-
Way ANOVA F(2, 29) = 5.294; P = 0.011; ∗∗P < 0.01 vs. shams,
Newman–Keuls Multiple Comparison Test]. Arrows in panels
9G1–G3 show that ectopic neurons (NeuN positive, red) are
also CytC positive (green), indicating these ectopic neurons are
apoptotic. About 90% of ectopic neurons are CytC positive.
DISCUSSION
Brain chronic hypoperfusion, caused in the elderly by partial
carotid occlusion, is a progressive, dynamic process that causes
multiple alterations as ischemic conditions persist, leading to neu-
rodegeneration (Farkas et al., 2007; Ozacmak et al., 2007) and
vascular dementia (Chmayssani et al., 2007).
In this research we used a model of brain chronic hypop-
erfusion obtained with the permanent 2VO (bilateral common
carotid artery occlusion) in the rat (Sarti et al., 2002a,b; Farkas
et al., 2007). As outlined by Farkas et al. (2007) the rat represents
a suitable animal species for this purpose since, after the bilat-
eral carotid artery occlusion, the complete circle of Willis affords
reduced, although continuous, blood flow to the brain (Otori
et al., 2003). Therefore, the rat 2VO model is useful to inves-
tigate the long-term effects of chronic cerebral hypoperfusion,
without exacerbating factors such as hypotension or hypoxia,
and reperfusion injury (Farkas et al., 2007). Furthermore, the
cerebral hypoperfusion is global and the damage to the nervous
tissue is chronic but less dramatic than in focal ischemic models,
and there are no obvious signs of motor dysfunction or seizures.
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FIGURE 7 | Evidence of triads and phagocytosis of neurons in CA1 Str.
Radiatum of 2VO-vehicle rats. Triple immunostaining of GFAP (green),
NeuN (red), and IBA1 (blue) in CA1 Str. Pyramidale and Str. Radiatum of
three different 2VO-vehicle rats. (A) Confocal 3D rendering of triple
immunostaining in the CA1 Str. Pyramidale and Str. Radiatum of a
2VO-vehicle rat obtained stacking three consecutive confocal z scans
(0.3µm each, total thickness 0.9µm acquired at 2.8µm depth into the
neuron). Arrows indicate an empty space that separates the neuron from
the surrounding CA1 pyramidal neurons. Scale bar: 5µm. (A1)
Magnification of the framed area in (A). The arrowhead shows that the
neuronal cytoplasm is inside the microglia cell body. Scale bar: 2µm. (B)
Confocal 3D rendering of triple immunostaining in the CA1 Str. Pyramidale
and Str. Radiatum of a different 2VO-vehicle rat. The image represents a 3D
rendering of 33 confocal scans (total thickness 9.9µm) acquired starting at
0.3µm depth into the slice. The ectopic neuron (open arrow) is in close
contact with both astrocyte branches and a microglia cell that resides on
top of the neuron and embraces it with its branches. Scale bar: 10µm.
(B1–B3) Magnifications of the framed area in (B). Astrocytes were omitted
for clarity. The open arrow in (B2) shows the lack of NeuN immunostaining
beneath the microglia cell, indicating that the microglia is phagocytosing the
neuron. Scale bar: 10µm. (C) Triple immunostaining in the CA1 Str.
Radiatum of a third 2VO-vehicle rat. This image represents a 3D rendering
of 37 confocal scans (total thickness 11.1µm) acquired starting at 3.6µm
depth into the slice. Two ectopic neurons (red) are surrounded by astrocyte
branches and phagocytosed by microglia cells. The open arrow shows a
fusiform-shaped microglia cell. Scale bar: 8µm. (C1–C3) Higher
magnification confocal “sub-slices” of the framed area in (C) obtained
stacking 12 consecutive confocal z scans (0.3µm each, total thickness
3.6µm acquired at 1.5µm depth into the neuron). Astrocytes were omitted
for clarity. Arrowheads in (C1) indicate colocalization of neuronal cytoplasm
within IBA1-positive reactive microglia cell. Open arrow in (C2) indicates
loss of NeuN staining. Scale bar: 5µm.
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FIGURE 8 | Quantitative analysis of triads in CA1 Str. Radiatum. Triple
immunostaining of GFAP (green), NeuN (red), and IBA1 (blue) in CA1 Str.
Radiatum of a sham (A), a 2VO-vehicle (B), and a 2VO-dipyridamole (C)
rat. (A) Confocal 3D rendering of triple immunostaining in CA1 Str.
Radiatum of a sham rat obtained stacking 35 consecutive confocal z
scans (0.3µm each, total thickness 10.5µm acquired at 5.4µm depth
into the slice). (B) Confocal 3D rendering of triple immunostaining in CA1
Str. Radiatum of a 2VO-vehicle rat obtained stacking 49 consecutive
confocal z scans (0.3µm each, total thickness 14.7µm). (C) Confocal 3D
rendering of triple immunostaining in CA1 Str. Radiatum of a
2VO-dypiridamole rat obtained stacking 30 consecutive confocal z scans
(0.3µm each, total thickness 9µm acquired at 6.9µm depth into the
slice). Note the absence of a direct interplay among neurons, astrocytes
and microglia in sham (A) and 2VO-dipyr (B). Scale bar in A–C: 15µm.
(D) Quantitative analysis of triads in CA1 Str. Radiatum of sham (n = 4),
2VO-vehicle (n = 5), and 2VO-dipyridamole (n = 4) rats (triads/mm2, mean
± s.e.m.; ∗∗∗P < 0.01 vs. sham and 2VO-dipyr rats; One-Way ANOVA and
Newman–Keuls Multiple Comparison Test).
Nevertheless, the CA1 region of the hippocampus results particu-
larly vulnerable to the 2VO-related pattern of hypoperfusion and
metabolic changes, leading to failure of neuronal signaling, and
to learning and memory disturbances in hippocampally-based
forms of memory (De Jong et al., 1999; Liu et al., 2005; Farkas
et al., 2006; Melani et al., 2010).
Immunohistochemistry for NeuN and confocal microscopy
analysis revealed the presence of significantly more numerous
“ectopic” pyramidal neurons in the CA1 Str. Radiatum of 2VO
rats, localized just outside the CA1 layer, likely deriving from
CA1 Str. Pyramidale. This phenomenon may represent a sign
of alteration and damage of the hippocampal CA1 Pyramidal
neurons. Indeed, it had been previously demonstrated that 4
weeks after 2VO significant neuronal damage was observed in
CA1 hippocampal region (Ohtaki et al., 2006). The neurons
we defined as ectopic neurons had a pyramidal shape, typi-
cal of pyramidal neurons, different from other neuronal cell
types, and were located within 100µm from the Str. Pyramidale.
As reported by Klausberger and Somogyi (2008), most of the
GABAergic hippocampal inhibitory interneurons are located in
the Str. Radiatum far from the Str. Pyramidale, and in the Str.
Lacunosum Molecularis, therefore most of ectopic neurons were
not GABAergic interneurons.
Using the triple immunostaining of neurons, astrocytes and
microglia we demonstrated that in the Str. Radiatum of 2VO-
vehicle rats many ectopic neurons were surrounded by astrocyte
branches and microglia to form the so-called triads. Triads were
significantly more numerous in the Str. Radiatum of 2VO-vehicle
rats than in the two other groups. Using immunostaining with
a marker for apoptosis we demonstrated that in CA1 of 2VO-
vehicle rats many ectopic pyramidal neurons were apoptotic.
With the digital sub-slicing technique developed in our labora-
tory (Cerbai et al., 2012), we demonstrated that many astrocyte
branches not only surrounded pyramidal ectopic neurons, but
also intermingled and penetrated the neuronal cytoplasm, possi-
bly to fragment the neuronal cell body and to give rise to cellular
debris. We thus hypothesized that the fragmentation of ectopic
pyramidal neurons might be a consequence of the apoptotic
process which these neurons were undertaking because of the
hypoxic state of the tissue after bilateral common carotid occlu-
sion. Fragmentation of apoptotic pyramidal neurons might be
triggered or accelerated by astrocyte branches infiltrating the neu-
ronal body, thus forming neuronal debris ready for phagocytosis
by microglia, as also demonstrated in other models of neurode-
generation (Polazzi andMonti, 2010; Cerbai et al., 2012; Huizinga
et al., 2012).
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FIGURE 9 | Immunofluorescence of CytC and quantitative analysis of
CytC positive neurons in CA1 Str. Pyramidale. (A–D) Confocal
immunostaining of neurons (NeuN, red), Cyt C (green), and microglia (IBA1,
blue) in CA1 Str. Pyramidale and Str. Radiatum. Panels (A–D) show a cell
“sub-slice,” obtained stacking 2 confocal z scans (0.3µm each, total
thickness 0.6µm acquired at 1.8µm depth into the neuron). Scale bar:
15µm. (D) Merge of the three above images showing the colocalization of
CytC with NeuN in the cytoplasm of an ectopic neuron and the close
proximity of a microglia cell projecting its branches to surround the neuron
(open arrow). The asterisk in the pyramidal cell layer shows an empty spot
possibly in correspondence to the place where the neuron was previously
located. Scale bar: 8µm. (E1–E3) Representative images showing CytC
positive neurons in the pyramidal cell layer of the three experimental groups
(arrows). Scale bar: 10µm. (F) Quantitative analysis of CytC positive neurons
in Str. Pyramidale of sham (white column, n = 10), 2VO-vehicle (black column,
n = 12), and 2VO-dipyridamole (gray column, n = 10) rats (CytC positive
neurons/mm2, mean ± s.e.m.; ∗∗P < 0.01 vs. sham; One-Way ANOVA and
Newman–Keuls Multiple Comparison Test). Quantification was performed
blind by two researchers in the region of interest (ROI) of CA1 Str. Pyramidale
(represented in E1–E3) and results were averaged. ROIs were calculated in
mm2 and the counts of CytC positive cells were expressed as neurons/mm2.
(G1–G3) Representative images showing that ectopic neurons are CytC
positive in the CA1 Str. Radiatum of the three experimental groups (arrows).
Scale bar: 15µm.
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Astrogliosis is generally considered a late-emerging event in
the hippocampus during chronic cerebral hypoperfusion (Pappas
et al., 1996; Farkas et al., 2004, 2006, 2007; Schmidt-Kastner et al.,
2005). Consistently, in our hands no sign of astrocyte prolifer-
ation was evident. Nevertheless, our results show that in CA1
of 2VO-vehicle rats, astrocytes were in a reactive state. Indeed,
astrocytes exhibited hypertrophic, interdigitated and frequently
overlapping processes, particularly in the surroundings of ectopic
neurons. Furthermore, in some instances we found that several
astrocytes surrounded ectopic neurons and formed a “micro scar”
around them. These events were consistently less frequent or
absent in sham and 2VO-dipyridamole rats. It has been reported
that reactive gliosis is a response of astrocytes to a variety of
brain insults, characterized by hypertrophy of the cell bodies and
processes, and increased GFAP expression (Ridet et al., 1997;
Barreto et al., 2011). As reported by Sofroniew (2009; Sofroniew
and Vinters, 2010), reactive astrogliosis is neither an all-or-none
response, nor a single uniform process, nor always synonymous
with scar formation. In moderate forms of reactive astrogliosis,
astrocyte proliferation is limited, astrocytes occupy contiguous
non-overlapping domains (Bushong et al., 2002) but have hyper-
trophic bodies and processes (Wilhelmsson et al., 2006). At its
extreme level of activation, reactive astrogliosis involves scar for-
mation with newly proliferated cells with overlapping processes. It
is generally believed that reactive astrogliosis and scar formation
protect neurons and tissue, restricting the spread of inflam-
mation and preserving brain functionality (Sofroniew, 2009).
Nevertheless, increasing evidence indicates that dysfunctions of
the process of reactive astrogliosis and scar formation poten-
tially contributes to, or is the primary cause of, neurodegenerative
mechanisms (Sofroniew, 2009). Our hypothesis is that the phe-
nomenon of infiltration of astrocytes branches inside the body of
the apoptotic-ectopic pyramidal neurons to trigger their disgre-
gation might be a dysfunction or an abnormality of the process of
reactive astrogliosis and could have the potential to contribute to
the pathophysiological mechanisms of brain chronic ischemia.
The model of brain chronic ischemia can be subdivided in
three phases: an acute phase (2–3 days) immediately after the
start of occlusion, characterized by hypoxia, shear stress, pro-
duction of reactive oxygen species (ROS) (Carden and Granger,
2000; Eltzschig and Carmeliet, 2011), and reduction of the nitric
oxide (NO) bioavailability (Yilmaz and Granger, 2010). This
phase is followed by a chronic phase (several weeks), and a resti-
tution phase in which the tissue undergoes compensatory and
adaptive mechanisms (Farkas et al., 2007; Dirnagl, 2012). As
reported by Iadecola and Anrather (2011), post-ischemic insult
is a self-limiting process that eventually subsides and prepares
the terrain for the structural and functional reorganization of the
injured brain. The factors governing the restitution phase and the
reestablishment of tissue homeostasis are still poorly understood.
Many evidences indicate that the restitution phase is orchestrated
by the interplay of numerous processes and mediators (Spite
and Serhan, 2010), including removal of dying/apoptotic cells,
development of an anti-inflammatory milieu, neurogenesis, and
generation of pro-survival factors stimulating tissue reconstruc-
tion and repair (Nathan and Ding, 2010; Spite and Serhan, 2010).
The hippocampal slices used in our experiments were obtained
from animals 3 months after bilateral common carotid occlusion,
a sufficient time-lapse for the tissue to undergo all the aforemen-
tioned adaptive processes of the restitution phase of brain chronic
ischemia.
Despite the increase of apoptotic neurons, of ectopic neurons
and of neuronal debris in hippocampal Str. Radiatum of 2VO-
vehicle rats, CA1 pyramidal neurons did not decrease in compar-
ison to sham rats, confirming previous reports that demonstrated
no loss of CA1 pyramidal neurons with age (Gallagher et al.,
1996). This effect could depend upon increased neurogenesis dur-
ing the restitution phase of brain chronic ischemia, as shown
in vivo (Farkas et al., 2007; Dirnagl, 2012) and in an acute in vitro
model of hypoxia on hippocampal slices (Maraula et al., 2013).
Newly generated neurons migrate from the subgranular zone
(SGZ) of the Dentate Gyrus (DG) to integrate the apoptotic neu-
rons in the CA1 pyramidal layer. Upregulation of neurogenesis
after an ischemic insult in hippocampal DG has been attributed to
cell death in the entorhinal cortex or in the CA1 region (Bernabeu
and Sharp, 2000).
Fluorescent immunostaining of the “triad” revealed that reac-
tive or amoeboid (Beynon and Walker, 2012) microglia cells were
phagocytosing ectopic pyramidal neurons in CA1 Str. Radiatum
of 2VO-vehicle rats. These phagocytic events were consistently
less frequent or absent in sham and 2VO-dipyridamole rats.
Using morphological analysis of IBA1 immunostained microglia
it was possible to evaluate their state of activation and to dis-
tinguish between resting and reactive microglia (Stence et al.,
2001; Nelson et al., 2002; Rezaie et al., 2002; Herber et al., 2006;
Miller and Streit, 2007). The quantification of resting, reactive
and total microglia cells revealed that in 2VO-vehicle rats there
was a significant decrease in total microglia in comparison to
sham rats and dipyridamole reverted this effect. It is not sur-
prising that the number of triads increases without significant
increase of microglia and/or astrocytes because triad formation
does not depend on the number of astrocytes or microglia, sepa-
rately, but depends on the close interaction and interplay among
neurons, astrocytes and microglia (usually phagocytic microglia).
It is therefore reasonable that the number of triads increases
even in the absence of any increase of the number of cells. The
percentage of resting/reactive microglia was not altered by the
ischemic conditions, and indeed sham, 2VO-vehicle and 2VO-
dipyridamole rats, all had about 60% of resting and 40% of
reactive microglia. These results onmicroglia population could be
interpreted as follows: the decrease of total microglia may depend
on the anti-inflammatory milieu promoted by the release of anti-
inflammatory cytokines during the restitution phase of brain
chronic hypoperfusion (Spite and Serhan, 2010). The production
of these cytokines is promoted by phagocytosis, occurs in con-
cert with the removal of dead cells (Nathan and Ding, 2010), and
may have both neuroprotective properties and anti-inflammatory
effects (Liesz et al., 2009). Therefore, post-ischemic production
of cytokines and/or endogenous glucocorticoids (Farkas et al.,
2002) can facilitate tissue repair by promoting the resolution of
inflammation and exerting direct cytoprotective effects on surviv-
ing cells in the ischemic area. The effect of the anti-inflammatory
cytokines could also explain the lack of modification in the
percentage of resting/reactive microglia in 2VO-vehicle rats in
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comparison to sham rats. Indeed, the anti-inflammatory milieu
could promote the recovery of the steady state level of activa-
tion of microglia cells that we found in shams. It would be of
interest to investigate the presence of an upregulation of reac-
tive microglia in the acute phase of brain chronic hypoperfusion,
taking hippocampal slices at earlier times after 2VO-vehicle.
It had previously been demonstrated that treatment with
dipyridamole significantly restores Morris water maze memory
90 days after 2VO (Melani et al., 2010). Dipyridamole was orig-
inally introduced in 1959 as an antianginal medication (Picano,
1989), and it has been shown to have beneficial effects in ther-
apy for secondary stroke prevention (Halkes et al., 2006). The
potent inhibition of platelet activation (Heptinstall et al., 1986)
and the reduction of thrombi formation in vivo (Elkeles et al.,
1968) accounts for this beneficial effects (Halkes et al., 2006).
Dipyridamole has been tested in our model of brain chronic
hypoperfusion to further evaluate its protective role on the hip-
pocampal CA1 region during the ischemic insult. It has been
demonstrated that cerebral blood flow is still significantly lower
than the control values 4 weeks after 2VO induction (Schmidt-
Kastner et al., 2001; Otori et al., 2003; Tomimoto et al., 2003),
returning to control values only 6 months after occlusion (Choy
et al., 2006). In arteries, chronic decrease of blood flow induces
inward remodeling (Buus et al., 2001; Loufrani et al., 2002), such
as enlargement and tortuosity of the basilar artery in response
to permanent 2VO-vehicle (Schmidt-Kastner et al., 2005; Kantor
et al., 2007) and this effect can take place in a period as short as 2
days (Buus et al., 2001). The increases of extracellular adenosine
(Figueredo et al., 1999), together with increased VEGF produc-
tion (Ernens et al., 2010), and the potentiation of the NO system
(Aktas et al., 2003; Venkatesh et al., 2010) help explaining the
vasodilatatory, and possibly the protecting effect of dipyridamole
in this rat model of hypoperfusion. Furthermore, as reported by
Venkatesh et al. (2010) dipyridamole alone in control animals
has a positive effect on blood flow and angiogenesis through
the nitrite/NO endocrine system. Furthermore, according to
Pattillo et al. (2011), dipyridamole alone increases NO levels
and decreases superoxide formation both in ischemic and non-
ischemic animals. These effects indicate a positive effect of dipyri-
damole even in non-ischemic conditions and were commented by
the authors that suggested the possible use of dipyridamole as an
unique preconditioning agent that increases NO/nitrite responses
(Venkatesh et al., 2010). Dipyridamole has pleiotropic pharma-
cological effects, such as antioxidant (Eisert, 2002; Blake, 2004;
Riksen et al., 2005; Hsieh et al., 2010) and anti-inflammatory
proprieties. Dipyridamole decreases the production of proinflam-
matory cytokines (Al Bahrani et al., 2007), chemokines (Weyrich
et al., 2005), inhibits matrix metalloprotease-9 (Weyrich et al.,
2005), COX-2 activity (Chen et al., 2006), and the neutrophil
adhesion to endothelium (Chello et al., 1999). We hypothesize
that the administration of dipyridamole during the acute phase
of brain chronic hypoperfusion is responsible for the smart oppo-
sition toward the progression of the pathophysiological mecha-
nisms of the ischemic insult. This hypothesis is sustained by the
reversion of many of the effects observed in 2VO-vehicle rats by
dipyridamole. Indeed, the drug reverted the significant increment
of apoptotic and ectopic pyramidal neurons in hippocampal CA1
and the infiltration of astrocytes branches inside the neuronal
body of ectopic pyramidal neurons. Further experiments are
needed to fully understand the mechanisms of dipyridamole in
rescuing the CA1 hippocampal region from the damages induced
by chronic hypoperfusion.
It is important to notice that the phenomenon that astro-
cytes, infiltrating and bisecting neurons, may help their frag-
mentation was firstly demonstrated in a recent paper from our
laboratory (Cerbai et al., 2012), in which we characterized the
interaction neurons-astrocytes-microglia in normal brain aging
and LPS-induced neurodegeneration in the rat. More recently,
Re et al. (2014) demonstrated that astrocyte-motoneuron inter-
actions are sufficient to trigger neurodegeneration in a model
of Amyotrophic Lateral Sclerosis (Re et al., 2014). Therefore,
this phenomenon seems to be a common mechanism underly-
ing many neurodegenerative processes. The frequency to which it
appears might depend upon, or might be the cause of, the burden
and severity of neurodegeneration.
CONCLUSIONS
Taken together, our results demonstrate the presence of neuronal
damage and alteration in the interplay between neurons and glia
in CA1 of 2VO-vehicle rats. The effect of dipyridamole to revert
or slow the progression of the pathophysiological mechanisms of
brain chronic hypoperfusion might depend upon its role as an
anti-inflammatory and vasodilatory drug during the acute phase
of the ischemic insult.
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